MedTrace Logo

Efficacy and Safety of Amodiaquine and Amodiaquine-Artesunate

NCT00238017 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2006-02-02

No results posted yet for this study

Summary

The purpose of this study is to compare the efficacy and safety of two antimalarial drug regimes, namely amodiaquine versus amodiaquine-artesunate, in the treatment of children with uncomplicated malaria. Also, genetic host factors which might influence efficacy and/or safety will be examined.

Conditions

Interventions

DRUG

amodiaquine-artesunate versus amodiaquine

Sponsors & Collaborators

  • University for Development Studies, Tamale, Ghana

    collaborator OTHER

  • Kintampo Health Research Centre, Ghana

    collaborator OTHER

  • Charite University, Berlin, Germany

    lead OTHER

Principal Investigators

  • Rowland N Otchwemah, PhD · University for Development Studies

  • Frank P Mockenhaupt, MD · Malaria Unit, Institute of Tropical Medicine, Charite University, Berlin, Germany

  • Seth Owusu-Agyei, PhD · Kintampo Health Research Centre, Ghana

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
6 Months
Max Age
59 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-10-31
Completion
2005-12-31

Countries

  • Ghana

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00238017 on ClinicalTrials.gov